EP3294283
Skömmtun á sakúbítríl-valsartan til meðhöndlunar á hjartabilun
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
9.5.2016EP published:
8.3.2023EP application number:
16722388.2
EP translation filed:
22.5.2023Grant published:
15.6.2023EPO information:
European Patent Register
Max expiry date:
8.5.2036Expiry date:
8.5.2026Next due date:
31.5.2026
Title in English:
SACUBITRIL-VALSARTAN DOSAGE REGIMEN FOR TREATING HEART FAILURELanguage of the patent:
English
Timeline
Today
9.5.2016EP application
8.3.2023EP Publication
22.5.2023Translation submitted
15.6.2023Registration published
8.5.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
RIZKALA, Adel RedmondAddress:
4002 Basel, CH
Name:
SHI, Victor ChengweiAddress:
4002 Basel, CH
Name:
CHEN, FabianAddress:
4002 Basel, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562159703 PDate:
11.5.2015Country:
US
Classification
Categories:
A61K 31/225, A61K 31/41, A61P 9/04
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 8.5.2023
Expires: 8.5.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 23.4.2024
Expires: 8.5.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 9.5.2025
Expires: 8.5.2026
Payer: Árnason Faktor ehf.